Department of Biomedicine, Faculty of Health Sciences, Aarhus University, Aarhus, Denmark.
J Physiol. 2013 Apr 15;591(8):2205-19. doi: 10.1113/jphysiol.2012.250852. Epub 2013 Jan 28.
Body water balance is regulated via the water channel aquaporin-2 (AQP2), which is expressed in the renal connecting tubule (CNT) and collecting duct (CD). The relative roles of AQP2 in the CNT and CD are not fully understood. To study the role of AQP2 in the CNT we generated a mouse model with CNT-specific AQP2 deletion (AQP2-CNT-knockout (KO)). Confocal laser scanning microscopy and immunogold electron microscopy demonstrated an absence of AQP2 in the CNT of AQP2-CNT-KO mice. Twenty-four hour urine output was significantly increased (KO: 3.0 ± 0.3 ml (20 g body weight (BW))(-1); wild-type (WT): 1.9 ± 0.3 ml (20 g BW)(-1)) and urine osmolality decreased (KO: 1179 ± 107 mosmol kg(-1); WT: 1790 ± 146 mosmol kg(-1)) in AQP2-CNT-KO mice compared with controls. After 24 h water restriction, urine osmolality was still significantly lower in AQP2-CNT-KO mice (KO: 2087 ± 169 mosmol kg(-1); WT: 2678 ± 144 mosmol kg(-1)). A significant difference in urine osmolality between groups before desmopressin (dDAVP) (KO: 873 ± 129 mosmol kg(-1); WT: 1387 ± 163 mosmol kg(-1)) was not apparent 2 h after injection, with urine osmolality increased significantly in both groups (KO: 2944 ± 41 mosmol kg(-1); WT: 3133 ± 66 mosmol kg(-1)). Cortical kidney fractions from AQP2-CNT-KO mice had significantly reduced AQP2, with no compensatory changes in sodium potassium chloride cotransporter (NKCC2), AQP3 or AQP4. Lithium chloride treatment increased urine volume and decreased osmolality in both WT and AQP2-CNT-KO mice. After 8 days of treatment, the AQP2-CNT-KO mice still had a significantly higher urine volume and lower urine osmolality, suggesting that the CNT does not play a significant role in the pathology of lithium-induced nephrogenic diabetes insipidus. Our studies indicate that the CNT plays a role in regulating body water balance under basal conditions, but not for maximal concentration of the urine during antidiuresis.
水通道蛋白-2(AQP2)通过水通道调节体液平衡,AQP2 在肾脏连接小管(CNT)和集合管(CD)中表达。AQP2 在 CNT 和 CD 中的相对作用尚未完全阐明。为了研究 AQP2 在 CNT 中的作用,我们生成了 CNT 特异性 AQP2 缺失(AQP2-CNT-KO(敲除))的小鼠模型。共聚焦激光扫描显微镜和免疫金电子显微镜显示 AQP2-CNT-KO 小鼠的 CNT 中缺乏 AQP2。AQP2-CNT-KO 小鼠 24 小时尿排量明显增加(KO:3.0±0.3ml(20g 体重(BW))(-1);野生型(WT):1.9±0.3ml(20g BW)(-1)),尿渗透压降低(KO:1179±107mosmolkg(-1);WT:1790±146mosmolkg(-1))与对照组相比。在 24 小时水限制后,AQP2-CNT-KO 小鼠的尿渗透压仍明显较低(KO:2087±169mosmolkg(-1);WT:2678±144mosmolkg(-1))。在给予去氨加压素(dDAVP)之前,两组之间的尿渗透压差异(KO:873±129mosmolkg(-1);WT:1387±163mosmolkg(-1))没有明显差异,但在 2 小时后两组的尿渗透压均显著增加(KO:2944±41mosmolkg(-1);WT:3133±66mosmolkg(-1))。AQP2-CNT-KO 小鼠的皮质肾部分的 AQP2 明显减少,钠钾氯共转运蛋白(NKCC2)、AQP3 或 AQP4 没有代偿性变化。氯化锂治疗增加了 WT 和 AQP2-CNT-KO 小鼠的尿量并降低了渗透压。经过 8 天的治疗,AQP2-CNT-KO 小鼠的尿量仍然明显较高,渗透压仍然较低,表明 CNT 在锂诱导的肾性尿崩症的发病机制中没有发挥重要作用。我们的研究表明,在基础条件下,CNT 在调节体液平衡方面发挥作用,但在抗利尿作用下,CNT 不参与尿液的最大浓缩。